REGISTERED NUMBER: 08695460 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 September 2025

for

Beechwood Medical Ltd

Page

Company information

1

Balance sheet

2

Notes to the financial statements

4

Directors:

Dr J M T Dean

Dr H Thorsteinsson

Registered office:

Kelso House

13 Grosvenor Road

Wrexham

LL11 1BS

Registered number:

08695460 (England and Wales)

Accountants:

Ridgway and Company

The Office,

Ffordd Pentre Bach,

Nercwys.

Mold

Flintshire

CH7 4EG

FIXED ASSETS

Intangible assets

4

1,210

1,210

Property, plant and equipment

5

83,915

94,412

85,125

95,622

CURRENT ASSETS

Inventories

34,554

29,312

Debtors

6

120,626

98,390

Cash at bank and in hand

22,678

31,267

177,858

158,969

CREDITORS

Amounts falling due within one year

7

79,080

86,908

NET CURRENT ASSETS

98,778

72,061

TOTAL ASSETS LESS CURRENT LIABILITIES

183,903

167,683

CREDITORS

Amounts falling due after more than one year

8

(24,426

)

(52,318

)

PROVISIONS FOR LIABILITIES

(20,979

)

(23,603

)

NET ASSETS

138,498

91,762

CAPITAL AND RESERVES

Called up share capital

1,000

2

Retained earnings

137,498

91,760

138,498

91,762

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 February 2026 and were signed on its behalf by:

Dr H Thorsteinsson - Director

Dr J M T Dean - Director

1.	STATUTORY INFORMATION

Beechwood Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER

Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

INTANGIBLE ASSETS

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of nil years.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

10% on cost

Plant and machinery

-

15% on reducing balance

Fixtures and fittings

-

25% on reducing balance

STOCKS

Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

HIRE PURCHASE AND LEASING COMMITMENTS

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2024 - 11 ) .

4.	INTANGIBLE FIXED ASSETS

Development

costs

£

COST

At 1 October 2024

and 30 September 2025

1,210

NET BOOK VALUE

At 30 September 2025

1,210

At 30 September 2024

1,210

5.	PROPERTY, PLANT AND EQUIPMENT

Improvements

Fixtures

to

Plant and

and

property

machinery

fittings

Totals

£

£

£

£

COST

At 1 October 2024

22,386

26,170

107,276

155,832

Additions

-

6,542

2,806

9,348

At 30 September 2025

22,386

32,712

110,082

165,180

DEPRECIATION

At 1 October 2024

11,191

10,898

39,331

61,420

Charge for year

2,239

2,321

15,285

19,845

At 30 September 2025

13,430

13,219

54,616

81,265

NET BOOK VALUE

At 30 September 2025

8,956

19,493

55,466

83,915

At 30 September 2024

11,195

15,272

67,945

94,412

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.9.25

30.9.24

£

£

Trade debtors

2,587

737

Other debtors

118,039

97,653

120,626

98,390

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.9.25

30.9.24

£

£

Bank loans and overdrafts

13,000

13,000

Hire purchase contracts

14,892

14,892

Trade creditors

14,152

17,265

Taxation and social security

35,608

39,678

Other creditors

1,428

2,073

79,080

86,908

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30.9.25

30.9.24

£

£

Bank loans

5,417

18,417

Hire purchase contracts

19,009

33,901

24,426

52,318